RankingsPricing
  1. JP-listed companies
  2. HISAMITSU PHARMACEUTICAL CO.,INC.
  3. Financials
  4. Cost of revenue

HISAMITSU PHARMACEUTICAL CO.,INC.【JP:4530】

Market cap
¥548.5B
P/E ratio
21.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Feb 28, 202564,810+3.31%
Feb 29, 202462,735+12.77%
Feb 28, 202355,630+10.98%
Feb 28, 202250,126+10.56%
Feb 28, 202145,337-15.08%
Feb 29, 202053,388-2.45%
Feb 28, 201954,727-1.73%
Feb 28, 201855,688+4.77%
Feb 28, 201753,155-8.85%
Feb 29, 201658,319+2.20%
Feb 28, 201557,063

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)